CNPase is a potential autoantigen in multiple sclerosis15, and variability in CNPase expression levels has been linked to neurological and psychiatric disorders, including Alzheimer’s disease, Down syndrome16, schizophrenia17, 18, 19, and schizophrenia-related catatonic depression20. This evidence concerns the gene CNP and Alzheimer disease.